Recent Posts

Monday Morning Recap: The Week (4.13.15-4.19.15) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on April 20, 2015 0 Comments
Monday Morning Recap: The Week (4.13.15-4.19.15) in Drug & Device Law & Policy

Here’s the Monday Morning Recap, the weekly(ish) post where we call out recent drug and device law and policy developments that caught our eye and made us think. 1. Last week, the Editorial Board of the LA Times wrote in favor of a $200 monthly out-of-pocket cap on specialty drugs for individuals with marketplace plans […]

Continue Reading »

Innovation Collaborative Tackles Persistent Problem of ER “Boarding” of Psychiatric Patients

Filed in Hospitals, Mental Health by on April 17, 2015 0 Comments
Innovation Collaborative Tackles Persistent Problem of ER “Boarding” of Psychiatric Patients

By Kate Greenwood Earlier this week, the South Jersey Behavioral Health Innovation Collaborative, a partnership among five southern New Jersey health systems, the New Jersey Hospital Association, and the Camden Coalition of Healthcare Providers, announced that it is embarking on a year-long project to study mental health care delivery in the region. As reported here, […]

Continue Reading »

No-Rehire Agreements a No-No in California?

Filed in Employment Law by on April 14, 2015 0 Comments
No-Rehire Agreements a No-No in California?

By Charles A. Sullivan As a case that casts light both on California law of restraint of trade and the structure of emergency service delivery in that state, the Ninth Circuit’s opinion in Golden v. California Emergency Physicians Medical Group is noteworthy. Add to that a fascinating backstory, some of which is only hinted at […]

Continue Reading »

Coverage and Care: Oversight and Transparency

Coverage and Care: Oversight and Transparency

Editor’s Note: This post from Seton Hall Law Professor John Jacobi is the fourth in a series of four growing out of a conference on insurance coverage of mental health and substance use disorder treatment that the law school’s Sentinel Project hosted earlier this month. You can find Part One here, Part Two here, and Part Three here. By […]

Continue Reading »

A New Cholesterol-Lowering Drug at What Price?

Filed in Drug Pricing by on April 2, 2015 0 Comments
A New Cholesterol-Lowering Drug at What Price?

By Kate Greenwood Cross-Posted at Bill of Health This summer, the Food and Drug Administration (FDA) is expected to approve the first entries in a new class of drugs that lower patients’ low-density lipoprotein (LDL) cholesterol levels by more than half, even those patients who are already taking other cholesterol-lowering medication. The new drugs are […]

Continue Reading »